Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." ?g. }

• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
• SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.